{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:48:57Z","timestamp":1786650537859,"version":"build-2736575974"},"reference-count":77,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Can Res Ther"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0973-1482.122508","type":"journal-article","created":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T06:47:48Z","timestamp":1385794068000},"page":"135","source":"Crossref","is-referenced-by-count":2,"title":["The potential therapeutic targets to bone pain induced by cancer metastasis"],"prefix":"10.4103","volume":"9","author":[{"given":"Jun","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0973-1482.122508-1","first-page":"220","volume-title":"Animal models of cancer pain","author":"Pacharinsak","year":"2008","journal-title":"Comp Med"},{"key":"key-10.4103\/0973-1482.122508-2","first-page":"412","volume-title":"Walker 256 tumor-bearing rats as a model to study cancer pain","author":"Brigatte","year":"2007","journal-title":"J Pain"},{"key":"key-10.4103\/0973-1482.122508-3","first-page":"585","volume-title":"Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons","author":"Honore","year":"2000","journal-title":"Neuroscience"},{"key":"key-10.4103\/0973-1482.122508-4","first-page":"832","volume-title":"Pain outcomes in patients with advanced breast cancer and bone metastases","author":"Cleeland","year":"2013","journal-title":"Cancer"},{"key":"key-10.4103\/0973-1482.122508-5","doi-asserted-by":"crossref","unstructured":"O\u2032Donnell PW, Clohisy DR. Bone Cancer and Pain. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. USA: John Wiley and Sons, Inc.; 2013. p. 720-7.","DOI":"10.1002\/9781118453926.ch87"},{"key":"key-10.4103\/0973-1482.122508-6","first-page":"646","volume-title":"A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss","author":"Lozano-Ondoua","year":"2010","journal-title":"Life Sci"},{"key":"key-10.4103\/0973-1482.122508-7","first-page":"328","volume-title":"Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition","author":"Kawamata","year":"2010","journal-title":"J Anesth"},{"key":"key-10.4103\/0973-1482.122508-8","first-page":"173","volume-title":"Reduction of bone cancer pain by activation of spinal cannabinoid receptor 1 and its expression in the superficial dorsal horn of the spinal cord in a murine model of bone cancer pain","author":"Furuse","year":"2009","journal-title":"Anesthesiology"},{"key":"key-10.4103\/0973-1482.122508-9","first-page":"27","volume-title":"Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia","author":"Honore","year":"2009","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-10","first-page":"251","volume-title":"SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain","author":"Niiyama","year":"2009","journal-title":"Br J Anaesth"},{"key":"key-10.4103\/0973-1482.122508-11","first-page":"38","volume-title":"Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain","author":"Hald","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"key-10.4103\/0973-1482.122508-12","first-page":"494","volume-title":"The application of genomic and molecular data in the treatment of chronic cancer pain","author":"Turabi","year":"2012","journal-title":"J Surg Oncol"},{"key":"key-10.4103\/0973-1482.122508-13","first-page":"72","volume-title":"Turning Oncogenes into Targets","author":"Ness","year":"2012","journal-title":"Immunogastroenterology"},{"key":"key-10.4103\/0973-1482.122508-14","first-page":"1759","volume-title":"Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ET(A) receptor antagonism","author":"Asham","year":"2001","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0973-1482.122508-15","first-page":"269","volume-title":"Implantation of tumoral XC cells induces chronic, endothelin-dependent, thermal hyperalgesia in mice","author":"Baamonde","year":"2004","journal-title":"Cell Mol Neurobiol"},{"key":"key-10.4103\/0973-1482.122508-16","first-page":"6231","volume-title":"Biology of bone cancer pain","author":"Goblirsch","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key-10.4103\/0973-1482.122508-17","first-page":"9355","volume-title":"Functional interactions between tumor and peripheral nerve: Morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain","author":"Wacnik","year":"2001","journal-title":"J Neurosci"},{"key":"key-10.4103\/0973-1482.122508-18","first-page":"479","volume-title":"Nociceptive characteristics of tumor necrosis factor-alpha in naive and tumor-bearing mice","author":"Wacnik","year":"2005","journal-title":"Neuroscience"},{"key":"key-10.4103\/0973-1482.122508-19","first-page":"92","volume-title":"Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists","author":"Lozano-Ondoua","year":"2013","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/0973-1482.122508-20","first-page":"183","volume-title":"Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture","author":"Jimenez-Andrade","year":"2007","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-21","first-page":"239","volume-title":"Microenvironmental regulation of metastasis","author":"Joyce","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"key-10.4103\/0973-1482.122508-22","first-page":"85","volume-title":"Tumor-induced injury of primary afferent sensory nerve fibers in bone cancer pain","author":"Peters","year":"2005","journal-title":"Exp Neurol"},{"key":"key-10.4103\/0973-1482.122508-23","first-page":"6","volume-title":"Central neuronal mechanisms in cancer-induced bone pain","author":"Gordon-Williams","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"key-10.4103\/0973-1482.122508-24","first-page":"277","volume-title":"Cancer statistics, 2010","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key-10.4103\/0973-1482.122508-25","first-page":"1125","volume-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0973-1482.122508-26","first-page":"1623","volume-title":"Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection","author":"Heumann","year":"1987","journal-title":"J Cell Biol"},{"key":"key-10.4103\/0973-1482.122508-27","doi-asserted-by":"crossref","unstructured":"Nakajima T, Ohtori S, Yamamoto S, Takahashi K, Harada Y: Differences in innervation and innervated neurons between hip and inguinal skin. Clin Orthop Relat Res 2008;466:2527-32.","DOI":"10.1007\/s11999-008-0432-z"},{"key":"key-10.4103\/0973-1482.122508-28","first-page":"644","volume-title":"Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas","author":"Black","year":"2008","journal-title":"Ann Neurol"},{"key":"key-10.4103\/0973-1482.122508-29","first-page":"179","volume-title":"Management of cancer-related pain","author":"Desandre","year":"2009","journal-title":"Emerg Med Clin North Am"},{"key":"key-10.4103\/0973-1482.122508-30","first-page":"1206","volume-title":"Orofacial pain onset predicts transition to head and neck cancer","author":"Lam","year":"2011","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-31","doi-asserted-by":"crossref","unstructured":"Devor M. Neuropathic pain: What do we do with all these theories? Acta Anaesthesiol Scand 2001;45:1121-7.","DOI":"10.1034\/j.1399-6576.2001.450912.x"},{"key":"key-10.4103\/0973-1482.122508-32","first-page":"8578","volume-title":"Artemin overexpression in skin enhances expression of TRPV1 and TRPA1 in cutaneous sensory neurons and leads to behavioral sensitivity to heat and cold","author":"Elitt","year":"2006","journal-title":"J Neurosci"},{"key":"key-10.4103\/0973-1482.122508-33","first-page":"496","volume-title":"The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain","author":"Gu","year":"2010","journal-title":"Eur J Pain"},{"key":"key-10.4103\/0973-1482.122508-34","first-page":"128","volume-title":"Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization","author":"Sevcik","year":"2005","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-35","first-page":"802","volume-title":"Hematopoietic colony-stimulating factors mediate tumor-nerve interactions and bone cancer pain","author":"Schweizerhof","year":"2009","journal-title":"Nat Med"},{"key":"key-10.4103\/0973-1482.122508-36","first-page":"1437","volume-title":"Prevalence of pain in patients with cancer: A systematic review of the past 40 years","author":"van","year":"2007","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0973-1482.122508-37","first-page":"4971","volume-title":"Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity","author":"Cl\u00e9zardin","year":"2005","journal-title":"Cancer Res"},{"key":"key-10.4103\/0973-1482.122508-38","first-page":"521","volume-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","author":"Honore","year":"2000","journal-title":"Nat Med"},{"key":"key-10.4103\/0973-1482.122508-39","first-page":"167","volume-title":"Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats","author":"Roudier","year":"2006","journal-title":"Clin Exp Metastasis"},{"key":"key-10.4103\/0973-1482.122508-40","first-page":"585","volume-title":"Denosumab for the treatment of bone metastases in advanced breast cancer","author":"Casas","year":"2013","journal-title":"Breast"},{"key":"key-10.4103\/0973-1482.122508-41","first-page":"1669","volume-title":"CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway","author":"Chen","year":"2013","journal-title":"Carcinogenesis"},{"key":"key-10.4103\/0973-1482.122508-42","first-page":"2534","volume-title":"The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas","author":"Perez-Gomez","year":"2013","journal-title":"Oncogene"},{"key":"key-10.4103\/0973-1482.122508-43","first-page":"1766","volume-title":"P2X7 receptor-deficient mice are susceptible to bone cancer pain","author":"Hansen","year":"2011","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-44","first-page":"2549","volume-title":"Systemic blockade of P2X3 and P2X2\/3 receptors attenuates bone cancer pain behaviour in rats","author":"Kaan","year":"2010","journal-title":"Brain"},{"key":"key-10.4103\/0973-1482.122508-45","doi-asserted-by":"crossref","unstructured":"Lam DK, Dang D, Zhang J, Dolan JC, Schmidt BL. Novel animal models of acute and chronic cancer pain: A pivotal role for PAR2. J Neurosci 2012;32:14178-83.","DOI":"10.1523\/JNEUROSCI.2399-12.2012"},{"key":"key-10.4103\/0973-1482.122508-46","first-page":"20","volume-title":"Acute PAR2 activation reduces GABAergic inhibition in the spinal dorsal horn","author":"Huang","year":"2011","journal-title":"Brain Res"},{"key":"key-10.4103\/0973-1482.122508-47","first-page":"643","volume-title":"The proteinase\/proteinase-activated receptor-2\/transient receptor potential vanilloid-1 cascade impacts pancreatic pain in mice","author":"Nishimura","year":"2010","journal-title":"Life Sci"},{"key":"key-10.4103\/0973-1482.122508-48","first-page":"5790","volume-title":"Protease-activated receptor 2 (PAR2) protein and transient receptor potential vanilloid 4 (TRPV4) protein coupling is required for sustained inflammatory signaling","author":"Poole","year":"2013","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0973-1482.122508-49","first-page":"1248","volume-title":"Nociceptor sensitization in pain pathogenesis","author":"Gold","year":"2010","journal-title":"Nat Med"},{"key":"key-10.4103\/0973-1482.122508-50","first-page":"14","volume-title":"A selective role for alpha3 Subunit glycine receptors in inflammatory pain","author":"Harvey","year":"2009","journal-title":"Front Mol Neurosci"},{"key":"key-10.4103\/0973-1482.122508-51","first-page":"221","volume-title":"Mechanisms that generate and maintain bone cancer pain","author":"Mantyh","year":"2004","journal-title":"Novartis Found Symp"},{"key":"key-10.4103\/0973-1482.122508-52","first-page":"763","volume-title":"Adenylate cyclase inhibition attenuates neuropathic pain but lacks pre-emptive effects in rats","author":"Liou","year":"2009","journal-title":"Can J Anaesth"},{"key":"key-10.4103\/0973-1482.122508-53","first-page":"710","volume-title":"Involvement of spinal PKA\/CREB signaling pathway in the development of bone cancer pain","author":"Hang","year":"2013","journal-title":"Pharmacol Rep"},{"key":"key-10.4103\/0973-1482.122508-54","first-page":"e27630","volume-title":"Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG) E2 and 15-deoxy-\u0394(12,14)-PGJ2","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"key-10.4103\/0973-1482.122508-55","first-page":"87","volume-title":"Spinal RhoA\/Rho kinase signalling pathway may participate in the development of bone cancer pain","author":"Hang","year":"2013","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"key-10.4103\/0973-1482.122508-56","first-page":"1609","volume-title":"The dual function cytokine IL-33 interacts with the transcription factor NF-kappaB to dampen NF-kappaB-stimulated gene transcription","author":"Ali","year":"1950","journal-title":"J Immunol (Baltimore, Md:"},{"key":"key-10.4103\/0973-1482.122508-57","first-page":"9021","volume-title":"The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1","author":"Cayrol","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0973-1482.122508-58","first-page":"20","volume-title":"IL-1, IL-18, and IL-33 families of cytokines","author":"Arend","year":"2008","journal-title":"Immunol Rev"},{"key":"key-10.4103\/0973-1482.122508-59","first-page":"383","volume-title":"The biological paths of IL-1 family members IL-18 and IL-33","author":"Smith","year":"2011","journal-title":"J Leukoc Biol"},{"key":"key-10.4103\/0973-1482.122508-60","first-page":"59","volume-title":"Interleukin-33 mediates formalin-induced inflammatory pain in mice","author":"Han","year":"2013","journal-title":"Neuroscience"},{"key":"key-10.4103\/0973-1482.122508-61","first-page":"172","volume-title":"Spinal Interleukin-33 and its receptor ST2 contribute to bone cancer-induced pain in mice","author":"Zhao","year":"2013","journal-title":"Neuroscience"},{"key":"key-10.4103\/0973-1482.122508-62","first-page":"100","volume-title":"Interleukin-17F: A Promising Candidate of Cancer Therapy","author":"Yan","year":"2012","journal-title":"Immunogastroenterology"},{"key":"key-10.4103\/0973-1482.122508-63","first-page":"3126","volume-title":"Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain","author":"Ghilardi","year":"2005","journal-title":"J Neurosci"},{"key":"key-10.4103\/0973-1482.122508-64","first-page":"19","volume-title":"A possible role for nerve growth factor in the augmentation of sodium channels in models of chronic pain","author":"Gould","year":"2000","journal-title":"Brain Res"},{"key":"key-10.4103\/0973-1482.122508-65","first-page":"73","volume-title":"Osteolytic bone metastasis in breast cancer","author":"Yoneda","year":"1994","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/0973-1482.122508-66","first-page":"482","volume-title":"Targeting astrocyte signaling for chronic pain","author":"Gao","year":"2010","journal-title":"Neurotherapeutics"},{"key":"key-10.4103\/0973-1482.122508-67","doi-asserted-by":"crossref","unstructured":"Liu S, Liu YP, Song WB, Song XJ. EphrinB-EphB receptor signaling contributes to bone cancer pain via Toll-like receptor and proinflammatory cytokines in rat spinal cord. Pain 2013; In Press. doi: 10.1016\/j.pain.2013.08.017","DOI":"10.1016\/j.pain.2013.08.017"},{"key":"key-10.4103\/0973-1482.122508-68","first-page":"168","volume-title":"EphrinB-EphB receptor signaling contributes to neuropathic pain by regulating neural excitability and spinal synaptic plasticity in rats","author":"Song","year":"2008","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-69","first-page":"21","volume-title":"Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats","author":"Wang","year":"2012","journal-title":"Mol Brain"},{"key":"key-10.4103\/0973-1482.122508-70","first-page":"1","volume-title":"Involvement of CX3CR1 in bone cancer pain through the activation of microglia p38 MAPK pathway in the spinal cord","author":"Hu","year":"2012","journal-title":"Brain Res"},{"key":"key-10.4103\/0973-1482.122508-71","first-page":"60","volume-title":"Involvement of spinal monocyte chemoattractant protein-1 (MCP-1) in cancer-induced bone pain in rats","author":"Hu","year":"2012","journal-title":"Neurosci Lett"},{"key":"key-10.4103\/0973-1482.122508-72","first-page":"434","volume-title":"Suppression of KCNQ\/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model","author":"Zheng","year":"2013","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-73","first-page":"80","volume-title":"Enhanced SCN7A\/Nax expression contributes to bone cancer pain by increasing excitability of neurons in dorsal root ganglion","author":"Ke","year":"2012","journal-title":"Neuroscience"},{"key":"key-10.4103\/0973-1482.122508-74","doi-asserted-by":"crossref","unstructured":"Qiu F, Jiang Y, Zhang H, Liu Y, Mi W. Increased expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 within dorsal root ganglia in a rat model of bone cancer pain. Neurosci Lett 2012;512:61-6.","DOI":"10.1016\/j.neulet.2012.01.069"},{"key":"key-10.4103\/0973-1482.122508-75","first-page":"216","volume-title":"Bilateral downregulation of Nav1.8 in dorsal root ganglia of rats with bone cancer pain induced by inoculation with Walker 256 breast tumor cells","author":"Miao","year":"2010","journal-title":"BMC Cancer"},{"key":"key-10.4103\/0973-1482.122508-76","first-page":"95","volume-title":"Tumor-induced mechanical hyperalgesia involves CGRP receptors and altered innervation and vascularization of DsRed2 fluorescent hindpaw tumors","author":"Wacnik","year":"2005","journal-title":"Pain"},{"key":"key-10.4103\/0973-1482.122508-77","first-page":"7343","volume-title":"Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2","author":"Sabino","year":"2002","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:19:48Z","timestamp":1786648788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0973-1482.122508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"alternative-id":["122508"],"URL":"https:\/\/doi.org\/10.4103\/0973-1482.122508","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}